Jaguar Health, Inc.
JAGX
$2.75
-$0.07-2.48%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 155.75% | -1.52% | 12.45% | 15.95% | 13.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 155.96% | -1.52% | 12.45% | 15.95% | 13.93% |
| Cost of Revenue | 116.52% | 93.04% | 2.21% | 3.98% | -3.86% |
| Gross Profit | 164.42% | -20.52% | 15.00% | 18.99% | 18.63% |
| SG&A Expenses | -0.38% | 16.05% | 19.78% | 22.46% | 15.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.35% | 33.16% | 10.58% | 7.43% | 2.73% |
| Operating Income | 20.39% | -46.31% | -9.92% | -4.66% | 0.78% |
| Income Before Tax | 14.33% | -37.57% | -7.08% | -14.37% | -4.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.33% | -37.57% | -7.08% | -14.37% | -4.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -25.63% | -25.82% | 27.57% | 41.07% | 36.68% |
| Net Income | 14.12% | -38.82% | -6.76% | -13.96% | -3.67% |
| EBIT | 20.39% | -46.31% | -9.92% | -4.66% | 0.78% |
| EBITDA | 21.75% | -49.30% | -10.64% | -5.12% | 0.40% |
| EPS Basic | 67.02% | 16.83% | -71.04% | -2,516.94% | -- |
| Normalized Basic EPS | 70.18% | 20.78% | -64.47% | -2,441.34% | -- |
| EPS Diluted | 67.02% | 16.83% | -71.04% | -2,516.94% | -- |
| Normalized Diluted EPS | 70.18% | 20.78% | -64.47% | -2,441.34% | -- |
| Average Basic Shares Outstanding | 399.26% | 85.48% | -4.70% | -26.54% | -- |
| Average Diluted Shares Outstanding | 399.26% | 85.48% | -4.70% | -26.54% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |